These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33839096)

  • 1. Obesity and no call results: optimal timing of cell-free DNA testing and redraw.
    Hopkins MK; Koelper N; Caldwell S; Dyr B; Dugoff L
    Am J Obstet Gynecol; 2021 Oct; 225(4):417.e1-417.e10. PubMed ID: 33839096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
    Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
    Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
    ; Prabhu M; Kuller JA; Biggio JR
    Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Fetal Fraction and Birth Weight in Women with Negative First-Trimester Cell-Free DNA Screening.
    Clapp MA; Berry M; Shook LL; Roberts PS; Goldfarb IT; Bernstein SN
    Am J Perinatol; 2020 Jan; 37(1):86-91. PubMed ID: 31739367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing.
    Benn P; Valenti E; Shah S; Martin K; Demko Z
    Obstet Gynecol; 2018 Aug; 132(2):428-435. PubMed ID: 29995728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining the use of a fetal fraction-based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy.
    Benn P; Martin K; McKanna T; Valenti E; Billings P; Demko Z
    J Genet Couns; 2020 Oct; 29(5):800-806. PubMed ID: 31872514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A statistical investigation of parameters associated with low cell-free fetal DNA fraction in maternal plasma for noninvasive prenatal testing.
    Pan Y; Pan X; Zhuang D; Zhou Y; Xue J; Wu S; Chen C; Li H
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2338440. PubMed ID: 38604949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women.
    Becking EC; Scheffer PG; Henrichs J; Bax CJ; Crombag NMTH; Weiss MM; Macville MVE; Van Opstal D; Boon EMJ; Sistermans EA; Henneman L; Schuit E; Bekker MN
    Am J Obstet Gynecol; 2024 Aug; 231(2):244.e1-244.e18. PubMed ID: 38097030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and cell-free DNA "no calls": is there an optimal gestational age at time of sampling?
    Livergood MC; LeChien KA; Trudell AS
    Am J Obstet Gynecol; 2017 Apr; 216(4):413.e1-413.e9. PubMed ID: 28153663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine fibroids and non-informative cell-free DNA screening results.
    Rolnik DL; Raymond Y; Lee T; Ramkrishna J; da Silva Costa F; Menezes M; Meagher S
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):463-469. PubMed ID: 39177335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
    Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
    J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free DNA fetal fraction and preterm birth.
    Dugoff L; Barberio A; Whittaker PG; Schwartz N; Sehdev H; Bastek JA
    Am J Obstet Gynecol; 2016 Aug; 215(2):231.e1-7. PubMed ID: 26875947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation use is associated with lower fetal fraction and more indeterminate results.
    Shree R; MacKinnon HJ; Hannan J; Kolarova TR; Reichel J; Lockwood CM
    Am J Obstet Gynecol; 2024 Jan; 230(1):95.e1-95.e10. PubMed ID: 37429430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal Aneuploidy: Screening and Diagnostic Testing.
    LeFevre NM; Sundermeyer RL
    Am Fam Physician; 2020 Apr; 101(8):481-488. PubMed ID: 32293844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.
    Lopes JL; Lopes GS; Enninga EAL; Kearney HM; Hoppman NL; Rowsey RA
    Prenat Diagn; 2020 Jun; 40(7):831-837. PubMed ID: 32274800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cell-free DNA fetal fraction and gestational diabetes.
    Hopkins MK; Koelper N; Bender W; Durnwald C; Sammel M; Dugoff L
    Prenat Diagn; 2020 May; 40(6):724-727. PubMed ID: 32091624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.
    Caldwell S; Almasri E; Schmidt L; Xu C; Dyr B; Wardrop J; Cacheris P
    Prenat Diagn; 2021 Oct; 41(11):1372-1379. PubMed ID: 33682142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Fetal Fraction on First Trimester Cell-Free DNA Aneuploidy Screening and Adverse Pregnancy Outcomes.
    Shook LL; Clapp MA; Roberts PS; Bernstein SN; Goldfarb IT
    Am J Perinatol; 2020 Jan; 37(1):8-13. PubMed ID: 31365936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.